Sort
21,281 grants matching “influenza”
Development of vaccines targeting a tick-borne phlebovirus
$215,821Paul F Bates · University Of Pennsylvania · R01 · FY2022 · AI
Developing and Applying Analytical Models of Influenza Transmission
$215,821Jelena Srebric · Univ Of Maryland, College Park · U19 · FY2022 · AI
The NS1 and M Genes of the 1918 Influenza Virus
$215,816Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · P01 · FY2006 · AI
Reagent Core
$215,812Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
Reagent Core
$215,812Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
Reagent Core
$215,812Peter Palese · Icahn School Of Medicine At Mount Sinai · U19 · FY2018 · AI
Molecular mechanisms for TNF-mediated inhibition of B lymphocyte function
$215,730Bonnie B. Blomberg · University Of Miami School Of Medicine · R21 · FY2013 · AI
Core C: Humoral and Serological Core
$215,647Scott Eric Hensley · Massachusetts General Hospital · U19 · FY2019 · AI
Development of needle-free, vectorless, RNA-based vaccines for HIV
$215,565Daniel Garrett Kavanagh · Massachusetts General Hospital · R21 · FY2009 · AI
Development of a nanoemulsion-based vaccine for chlamydia infection
$215,532Ali I. Fattom · Bluewillow Biologics, Inc. · R43 · FY2018 · AI
Evaluation of HIV-1 Env intracytoplasmic domain as an AIDS vaccine immunogen
$215,475Ronald C Montelaro · University Of Pittsburgh At Pittsburgh · R21 · FY2006 · AI
Hierarchical Modeling/Ion Channel and Receptor Mechanism
$215,440Maria G Kurnikova · Carnegie-Mellon University · R01 · FY2007 · GM
Structural Studies of Alphavirus Membrane Fusion In Situ
$215,414Wei Zhang · University Of Minnesota · R21 · FY2009 · AI
High efficiency particulate air cleaner intervention to reduce respiratory virus exposure in elementary schools
$215,387Peggy Sue Lai · Massachusetts General Hospital · R21 · FY2024 · AI
Title: Role of Heparan sulfate in B-cell responses
$215,359Laurent Coscoy · University Of California Berkeley · R21 · FY2012 · AI
Identifying host genetic determinants that regulate dendritic cell activation
$215,331Mehul Shamal Suthar · Emory University · R21 · FY2016 · AI
"Optical Tympanostomy Tube" for prevention and treatment of tympanostomy tube otorrhea
$215,250Tianhong Dai · Massachusetts General Hospital · R21 · FY2023 · DC
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses
$215,100Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Nanoengineered virus-mimics as templates for design of a universal influenza A va
$215,097Harvinder Singh Gill · Texas Tech University · R21 · FY2012 · AI
IMMUNOGENICITY AND SAFETY OF A SPLIT, INACTIVATED, TRIVALENT INFLUENZA VACCINE
$215,043Robert Frenck · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · M01 · FY2006 · RR
Defining the MHC-II processing and presentation landscape of HIV-1
$215,000Laurence Crane Eisenlohr · Children'S Hosp Of Philadelphia · R21 · FY2019 · AI
Study of Novel Influenza C Virus
$214,980Feng Li · South Dakota State University · R21 · FY2014 · AI
Correction of defective deltaF508-CFTR processing in cystic fibrosis
$214,979Gergely L. Lukacs · Hospital For Sick Chldrn (Toronto) · R01 · FY2007 · DK
Vitamin D and Immunosenescence in Older Long-Term Care Residents
$214,918Adit A. Ginde · University Of Colorado Denver · K23 · FY2012 · AG
MECHANISMS OF TCDD PULMONARY IMMUNOTOXICITY
$214,683Washington State University · R01 · FY2002 · ES